Comparison of corticoid substitution versus combined oral contraception administration in the treatment of non-classic adrenal hyperplasia: A prospective study

Gynecological Endocrinology

Volumn 25, Issue 6, 2009, Pages 398-402

  Fanta, Michael ^a   Hill, Martin ^b   Blek, Jaromr ^c   Vrbkov, Jana ^b   Cibula, David ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Combined oral contraception; Corticosteroid; Hyperandrogenemia; NCAH; SHBG

Indexed keywords

ANDROSTENEDIONE; DESOGESTREL; ETHINYLESTRADIOL; FOLLITROPIN; HYDROCORTISONE; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ACNE; ADRENAL HYPERPLASIA; ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HIRSUTISM; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OBESITY; OLIGOMENORRHEA; ORAL CONTRACEPTION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADRENAL CORTEX HORMONES; ADRENAL GLAND DISEASES; ADULT; ANDROGENS; CONTRACEPTIVES, ORAL, COMBINED; CROSS-OVER STUDIES; FEMALE; HUMANS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 70350597498     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590902730770     Document Type: Article

References (8)

1. Fanta M, Cibula D, Vrbikova J. Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women. Gynecol Endocrinol 2008;24:154-157.
2. Carmina E, Rosato F, Janni A, Rizzo M, Longo RA. Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 2006;91:2-6.
3. Winterer J, Chrousos GP, Loriaoux DL, Cutler BG. Effect of hydrocortisone dose schedule on adrenal steroid secretion in congenital adrenal hyperplasia. J Pediatr 1985;106:137-142. (Pubitemid 15189926)
4. Spritzer P, Billaud L, Thalabard JCh, Birman P, Mowszowicz I, Raux-Demay MC, Kuttenn F, Mauvais-Jarvis P. Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia. J Clin Endocrinol Metab 1990;70:642-666.
5. Carmina E, Lobo RA. Ovarian supression reduces clinical and endocrine expression of l late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Fertil Steril 1994;62:738-743.
6. Coenen CM, Thomas CM, Borm GF, Hollanders JM, Rolland R. Changes in androgens during treatment with four low-dose contraceptives. Contraception 1996;53:171-176.
7. Moutos D, Smith S, Zacur H. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial. Contraception 1995;52:105-109.
8. Wiebe RH, Morris CV. Effect of an oral contraceptive on adrenal and ovarian androgenic steroids. Obstet Gynecol 1984;63:12-14.